Form 8-K - Current report:
SEC Accession No. 0001641172-25-023840
Filing Date
2025-08-14
Accepted
2025-08-14 13:11:17
Documents
13
Period of Report
2025-08-08
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 44093
  Complete submission text file 0001641172-25-023840.txt   262708

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cdt-20250808.xsd EX-101.SCH 3882
3 XBRL DEFINITION FILE cdt-20250808_def.xml EX-101.DEF 27219
4 XBRL LABEL FILE cdt-20250808_lab.xml EX-101.LAB 37682
5 XBRL PRESENTATION FILE cdt-20250808_pre.xml EX-101.PRE 25840
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6319
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CDT Equity Inc. (Filer) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41245 | Film No.: 251216835
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)